0 CHECKOUT

Analgesics in Mexico

  • ID: 227073
  • March 2015
  • Region: Mexico
  • 33 pages
  • Euromonitor International

In 2014 topical analgesics/anaesthetic showed strong growth of 12% in current value terms, and represented a 15% share of value sales in analgesics. This can mainly be explained by the increase in people doing exercise, which led to demand for more products for relieving muscle pain, and by the fact that OTC analgesics are preferred for their fast relief of pain caused by everyday stress.

The Analgesics in Mexico report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2010-2014, allowing you to identify the sectors driving growth. Forecasts to 2019 illustrate how the market is set to change.

Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
- Get a detailed picture of the Analgesics market;
- Pinpoint growth sectors and identify factors driving change;
- Understand the competitive environment, the market’s major players and leading brands;
- Use five-year forecasts to assess how the market is predicted to develop.

Note: Product cover images may vary from those shown

ANALGESICS IN MEXICO

March 2015

LIST OF CONTENTS AND TABLES

Headlines
Trends
Competitive Landscape
Prospects
Category Data
Table 1 Sales of Analgesics by Category: Value 2009-2014
Table 2 Sales of Analgesics by Category: % Value Growth 2009-2014
Table 3 Sales of Topical Analgesics/Anaesthetic by Format: % Value Breakdown 2009-2014
Table 4 NBO Company Shares of Analgesics: % Value 2010-2014
Table 5 LBN Brand Shares of Analgesics: % Value 2011-2014
Table 6 Forecast Sales of Analgesics by Category: Value 2014-2019
Table 7 Forecast Sales of Analgesics by Category: % Value Growth 2014-2019
Bayer De México SA De Cv in Consumer Health (mexico)
Strategic Direction
Key Facts
Summary 1 Bayer de México: Key Facts
Summary 2 Bayer de México: Operational Indicators
Company Background
Production
Summary 3 Bayer de México SA de CV: Production Statistics 2014
Competitive Positioning
Summary 4 Bayer de México SA de CV: Competitive Position 2014
Genomma Lab Internacional Sab De Cv in Consumer Health (mexico)
Strategic Direction
Key Facts
Summary 5 Genomma Lab Internacional SAB de CV: Key Facts
Summary 6 Genomma Lab Internacional SAB de CV: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 7 Genomma Lab Internacional SAB de CV: Competitive Position 2014
Novartis Farmacéutica SA De Cv in Consumer Health (mexico)
Strategic Direction
Key Facts
Summary 8 Novartis Farmaceútica SA de CV: Key Facts
Summary 9 Novartis Farmaceútica SA de CV: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 10 Novartis Farmaceútica SA de CV: Competitive Position 2014
Executive Summary
Consumer Health Remains Stable
Private Label and Generics Are Positioned Strongly
Domestic Manufacturers Demonstrate Positive Performances
the Distribution of Consumer Health Products Sees Important Changes
Moderate Growth Expected Over the Forecast Period
Key Trends and Developments
Major Changes in the Distribution and Logistics of Consumer Health Products
Chained Pharmacies Has A New Player
Safe Collection of Expired Medicines
Market Indicators
Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2009-2014
Table 9 Life Expectancy at Birth 2009-2014
Market Data
Table 10 Sales of Consumer Health by Category: Value 2009-2014
Table 11 Sales of Consumer Health by Category: % Value Growth 2009-2014
Table 12 NBO Company Shares of Consumer Health: % Value 2010-2014
Table 13 LBN Brand Shares of Consumer Health: % Value 2011-2014
Table 14 Distribution of Consumer Health by Format: % Value 2009-2014
Table 15 Distribution of Consumer Health by Format and Category: % Value 2014
Table 16 Forecast Sales of Consumer Health by Category: Value 2014-2019
Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2014-2019
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventive Medicine
Definitions
Sources
Summary 11 Research Sources

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

PLEASE SELECT A FORMAT

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a site license, allowing all users within a given geographical location of your organisation access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is an enterprise license, allowing all employees within your organisation access to the product.

HAVE A QUESTION?

If you have a more general question about our products please try our

FAQ SECTION

RELATED PRODUCTS

Our Clients

  • Johnson & Johnson Services, Inc.
  • Procter & Gamble Co.
  • Sanofi S.A.
  • GlaxoSmithKline PLC
  • Novartis AG
  • Pfizer, Inc.
  • Boehringer Ingelheim GmbH